NLA GUIDELINES Bundle (free trial)

Dyslipidemia-II NLA

Official NLA Dyslipidemia Guidelines Appsbrought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512431

Contents of this Issue

Navigation

Page 28 of 37

29 Chart 12. American Indians/Alaska Natives (AIs/ANs) Recommendations Strength Quality Clinicians should be aware that AIs/ANs have higher prevalence and incidence rates for ASCVD, and that certain ASCVD risk factors (e.g., obesity, metabolic syndrome, diabetes mellitus, and cigarette smoking ) are more common among AIs/ANs than NHWs, whereas prevalence values for hypertension and hypercholesterolemia are comparable or slightly elevated compared to NHWs. A Moderate In general, clinicians should screen for and manage dyslipidemia in AI/AN patients using the approach outlined in the NLA Expert Panel Recommendations for Patient- Centered Management of Dyslipidemia – Part 1. Because of the high prevalence of obesity, metabolic syndrome, and diabetes mellitus in AI/AN populations, strong emphasis should be on lifestyle therapies. A Moderate Clinicians should generally assess risk in AI/AN patients using the risk assessment approach outlined in the NLA Expert Panel Recommendations for Patient-Centered Management of Dyslipidemia – Part 1. B Low

Articles in this issue

Archives of this issue

view archives of NLA GUIDELINES Bundle (free trial) - Dyslipidemia-II NLA